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Abstract
Background: Fusobacterium necrophorum is a well-known cause of Lemirre’s disease and accumulating evidence
support its pathogenic role in peritonsillar abscess while its role in recurrent and chronic tonsillitis is uncertain. The
objective of this study was to assess the prevalence of oropharyngeal colonisation with F. necrophorum and
Beta-haemolytic streptococci in a cohort of patients scheduled for tonsillectomy due to recurrent or persistent throat
pain, and to evaluate the dynamics of colonisation with repeated sampling during a follow-up time of 6 to 8 months.
Methods: Fifty-seven (57) patients aged 15–52 years scheduled for tonsillectomy due to chronic/recurrent tonsillitis or
recurrent peritonsillar abscess were included. Throat swabs for the detection of F. necrophorum and Beta-haemolytic
streptococci and clinical data was collected at inclusion, at the time of surgery and 6 to 8 months after surgery.
Statistical analysis was performed using the Chi-square, Fisher’s exact and Mc Nemar tests.
Results: Fusobacterium necrophorum was found in 28, 30 and 16 % of the patients at inclusion, surgery and follow up
respectively. The corresponding results for beta-haemolytic streptococci were 5, 9 and 5 %. Patients colonised with
F. necrophorum at follow-up, after tonsillectomy, were equally relieved from their previous throat pain as non-colonised
patients. Looking at individual patients, the culture results for F. necrophorum varied over time, indicating a transient
colonisation.
Conclusion: Fusobacterium necrophorum was frequently found in throat cultures in this cohort of patients with
recurrent or chronic throat pain leading to tonsillectomy. Colonisation was equally frequent in the asymptomatic
cohort post-tonsillectomy, indicating that F. necrophorum is not alone causative of the symptoms. In an individual
perspective, colonisation with F. necrophorum was transient over time.
Keywords: Fusobacterium necrophorum, Tonsillectomy, Recurrent tonsillitis, Chronic tonsillitis, Persistent sore
throat syndrome, Aetiology, Treatment
Background
Recurrent or persistent sore throat is a significant health
problem mainly affecting adolescents and young adults.
Recurrent tonsillitis (RT), chronic tonsillitis (CT) and per-
sistent sore throat syndrome (PSTS) are sometimes over-
lapping diagnoses used for this patient group. The
definition of RT includes repeated bouts of acute tonsillitis
(AT) within a time span of less than a few years [1–3] and
the diagnoses CT and PSTS both refer to a condition with
recurrent or persisting throat symptoms of lower intensity.
In severe or protracted cases, patients suffering from RT,
CT and PSTS are often subjected to tonsillectomy. Peri-
tonsillar abscess is a purulent infection between the
tonsillar capsule and the pharyngeal constrictor muscle
regarded as a complication of acute tonsillitis [4]. Re-
lapse of this condition is another indication for tonsil-
lectomy according to national Swedish guidelines [5].
Despite being one of the most common causes of surgi-
cal intervention in young adults, the aetiology of RT and
CT/PSTS is insufficiently researched. Beta-haemolytic
Streptococcus group A (GAS) is considered the main
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bacterial pathogen in AT [6], and recurrent or relapsing in-
fection with GAS is regarded an important cause of RT [7].
However, the aetiology of RT is more complex as other bac-
teria have been proposed to play a pathogenic role [8, 9],
and formation of biofilms [10] as well as alterations of the
normal flora [11] have been suggested to be important for
the relapsing nature of the condition.
During the last decade, the anaerobic, pleomorphic
Gram-negative rod Fusobacterium necrophorum has been
suggested to play an important pathogenic role in acute
and recurrent tonsillitis as well as in persistent sore throat
syndrome [12–15]. It has likewise been put forward as a
major pathogen in peritonsillar abscesses [4, 16]. Fusobac-
terium necrophorum has since the 1930’s been known to
cause the life-threatening septic disease Lemierre’s syn-
drome, but it has also been considered a part of the normal
human oropharyngeal flora [17]. Some recent studies [12,
18, 19] have however not been able to detect the bacterium
in throat swabs and tonsil core biopsies of asymptomatic
subjects, while others [14, 20, 21] have reported a carriage
rate of 3.5–21 % in healthy controls.
In order to investigate the dynamics of oropharyngeal
colonisation with F. necrophorum in patients with severe
and protracted throat symptoms, we performed a longi-
tudinal cohort study with a focus on this bacterium in
patients subjected to tonsillectomy.
The aim of the study was to assess the prevalence of
F. necrophorum and beta-haemolytic streptococci in throat
swabs of patients scheduled for tonsillectomy because of re-
current tonsillitis, peritonsillar abscess or chronic tonsillitis/
recurrent sore throat syndrome, and to compare this with
the prevalence in the same patients at the time of surgery
and 6 to 8 months postoperatively.
Methods
A prospective cohort study was performed in the setting of
Växjö Central Hospital’s ENT-department, a secondary care
facility in southern Sweden serving a population of approx.
126 000. 61 patients, aged >15 years, scheduled to undergo
tonsillectomy due to infectious tonsillar disease, were in-
cluded between January 2011 and March 2012 (14 months).
Written informed consent was obtained from all patients or,
if patients were under 18 years of age, from a parent. Indica-
tions for tonsillectomy were: more than one peritonsillar ab-
scess, recurrent tonsillitis with symptoms interfering with
normal daily activities or chronic tonsillitis/persistent sore
throat syndrome with symptoms interfering with normal
daily activities. The latter entity was for study purposes
defined as recurrent or persistent sore throat without well-
defined bouts of acute tonsillitis and is hereafter called
chronic tonsillitis (CT). All included patients filled in a ques-
tionnaire regarding their history of throat pain and anti-
biotic treatment during the preceding year. The attending
otorhinolaryngologist filled in a questionnaire including
previous medical history, indication for tonsillectomy and,
if applicable, current infection and antibiotic treatment.
Throat swabs (Amies transport medium, Copan, Italy) were
obtained from all patients by the including physician fol-
lowing a standardized routine where the swab was rubbed
on the surfaces of both tonsils. At the day of tonsillectomy,
a new throat swab was obtained by the operating otorhino-
laryngologist after the induction of anaesthesia. Finally, all
included patients were offered a control visit 6–8 months
postoperatively. All control visits were conducted by the
primary investigator (HB). At this visit the patients filled in
a new questionnaire regarding throat symptoms and a third
throat swab was obtained, now from the tonsillar fossae.
Samples were intended for study purposes only and the
physician was not informed of the results. If needed, the
treating physician had the possibility to take another
swab for clinical decision-making.
All samples were stored in fridge until transport to the
Department of Clinical Microbiology, Central Hospital,
Växjö. Throat swabs were cultured for the recovery of
beta-haemolytic streptococci (Lancefield group A, C and
G), using a double layered agar (Columbia agar [Oxoid,
Basingstokes, UK] covered with sheep Blood Agar, Blood
agar base [Merck, Darmstadt, Germany] with 5 % sheep
blood [SVA, Uppsala, Sweden] and 5 mg/ml methyl violet
[Merck, Darmstadt, Germany] with a bacitracin disc
(0.2 IU)). For F. necrophorum a selective anaerobic agar
(Fastidious anaerobe agar [Lab M] with 5 % horse blood
[Håtuna Lab AB, Bro, Sweden] supplemented with vanco-
mycin 2.5 mg/L [ICN Biomedicals] and nalidixic acid
5.0 mg/L [MP biomedicals]) and with a kanamycin tablet
500 μg (Rosco, Taastrup, Denmark) was used. The agar
plates were incubated under anaerobic conditions in
35–37 °C for 1 and 4 days respectively. For species identi-
fication, Streptex (Remel Europe Ltd. Dartford, England)
and MALDI-TOF (Microflex™ mass-spectrometer and Bioty-
per 3.1 software, Bruker Daltonics, Bremen, Germany) was
used. Only large colony variants of Beta-hemolytic streptococci
were further analysed to allow a relevant group-classification.
SPSS 20.0 software for Windows was used for all statistical
analyses. For descriptive statistics, median values and propor-
tions were used. Comparisons between proportions of cat-
egorical variables in two independent groups were performed
using the Chi-square test or Fisher’s exact test (two-sided),
when expected frequencies were small. When the variables
were considered dependent, the Mc Nemar test was used.
P-values≤ 0.05 were considered statistically significant.
The study was approved by the Regional Ethics Board
in Linköping, Dnr 2010/267-31.
Results
Inclusion
Sixty-one patients were included in the study. Of these,
four were excluded because of insufficient inclusion
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data. Resulting 57 patients were aged 15–52 years, me-
dian age 19. Forty-two were female and 15 male. Half
the group (n = 28) had CT as their only indication for
tonsillectomy while the other half had RT, PTA or a
combination of the diagnoses (Table 1). At inclusion, 8
patients were on treatment with antibiotics due to acute
infections. (PTA n = 5, AT n = 2 and infected umbilical
piercing n = 1). Three patients were diagnosed with
tonsillar infection at inclusion (PTA n = 1, AT n = 2) and
received antibiotic treatment after sampling. An add-
itional 2 patients received antibiotics (clindamycin) as
part of the treatment for RT, despite paucity of current
infectious signs.
Fusobacterium necrophorum was detected in 16 of 57
throat swabs (28 %) and beta-haemolytic streptococci in
three (5 %), one of which was group A streptococci
(GAS) and two group G streptococci (GGS) (Table 2).
No throat swab showed growth of more than one of the
mentioned bacteria. Of the ten patients presenting with
acute tonsillar infection at inclusion, six had a positive
culture for F. necrophorum and one had growth of GAS.
No significant correlations were shown between a positive
culture for F. necrophorum and tonsillar hypertrophy (9/16
vs 16/41 p = 0.24 Chi square test) or self-reported history of
mononucleosis (1/16 vs 12/41 p = 0.08 Fishers exact test).
Baseline characteristics did not differ between culture
positive and culture negative patients (Data not shown).
Further, the frequency and severity of throat pain, asso-
ciated febrile disease and number of prescribed antibiotic
treatments the last year was similarly not associated with
the presence of F. necrophorum or beta-haemolytic
streptococci at baseline (Data not shown).
Sampling at the time of surgery
Tonsillectomy was performed on 55 of the scheduled 57
patients, while 2 patients ultimately declined surgery. The
operation was performed 1–132 days after inclusion
(median 44 days). Perioperative throat swabs were
obtained from 47 patients. On the day of tonsillectomy,
7 out of the 16 previously culture positive patients were
positive for F. necrophorum. Another 7 patients had
growth of F. necrophorum despite being culture negative
at inclusion (Table 3). Two patients had concomitant
Table 1 Culture results at inclusion in relation to baseline data








Age 15–20 32 12 3 17
21–25 13 3 0 10
26–30 7 0 0 7
>30 5 1 0 4
Sex Male 15 4 0 11
Female 42 12 3 27
Indication
for TE
Recurrent Tonsillitis (RT) 14 4 0 10
Peritonsillar Abscess (PTA) 4 2 0 2
Chronic Tonsillitis (CT) 28 8 2 18
RT + PTA 3 0 0 3
PTA + CT 1 1 0 0
RT + CT 6 1 1 4
Othera 1 0 0 1
Current PTA
at inclusion
6 3 0 3




8 4 0 4
History of
mononucleosis
13 1 2 10
Tonsillar hypertrophy 25 9 2 14
aOne patient with a previous episode of severe acute tonsillitis
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growth of F. necrophorum and beta-haemolytic streptococci
(one group C streptococci, GCS, and one GGS) and 2
patients were positive for beta-haemolytic streptococci only
(one GCS and one GGS). To summarize, F. necrophorum
was found in 14/47 (30 %) and Beta-haemolytic strepto-
cocci in 4/47 (9 %) of patients (Table 2).
Sampling at the time of follow-up
Forty-three of the 57 included patients (75 %) showed
up for a follow-up visit 6 to 8 months postoperatively.
All but one considered themselves cured. Seven out of
these 43 patients (16 %) were positive for F. necrophorum
(Table 2). Out of those seven, three had not had a positive
culture for F. necrophorum before, while three had had
positive cultures both at inclusion and surgery and one
only at surgery (Table 3). Two patients (5 %) had positive
cultures for beta-haemolytic streptococci, one of which
was GCS and one GGS.
In order to compare the prevalence of F. necrophorum at
inclusion with the prevalence at follow up, a Mc Nemar
analysis was performed, showing no statistically significant
difference. Only patients sampled at both occasions (n = 43)
were included in this analysis. (11/43 vs 7/43 p = 0.39,
Mc Nemar test).
Discussion
In this study, throat cultures for F. necrophorum and
beta-haemolytic streptococci were obtained pre-, per-
and postoperatively from a cohort of patients scheduled
for tonsillectomy due to infectious tonsillar disease. To
our knowledge, this is the first study with a longitudinal
approach to assess the prevalence of F. necrophorum in
the same subjects over time. It is also the first study aimed
to compare the prevalence of F. necrophorum before and
after tonsillectomy in a cohort of patients. We found a
high prevalence of Fusobacterium necrophorum both
pre- and post-tonsillectomy in our selected patient cohort.
Table 2 Results of throat cultures per main diagnosis at different sampling times
Recurrent tonsillitis (RT) (n = 20) Peritonsillar abscess (PTA) (n = 8) Chronic tonsillitis (CT) (n = 28) Total (n = 56)a
Inclusion (n = 56a) 5/1/14 3/0/5 8/2/18 16/3/38
Surgery (n = 47) 6/0/10 2/1/4 6/3/17b 14/4/31b
Follow-up (n = 43) 2/1/10 1/1/5 4/0/19 7/2/34
(F.necrophorum /beta-haemolytic streptococci/negative)
aOne additional patient included because of a history of severe tonsillitis had a negative culture at inclusion and denied surgery, lost to follow-up
b2 samples were positive for both F. necrophorum and beta-haemolytic streptococci
Table 3 Patients positive for Fusobacterium necrophorum. Culture results from three different samplings, visualizing the dynamics of
colonisation in individuals. Patients were scheduled for tonsillectomy due to peritonsillar abscess, recurrent tonsillitis or chronic tonsillitis
Inclusion Surgery after 1–132 days Follow-up after 6 months
Positive n = 3
Positive n = 7 Negative n = 1
Lost to follow up n = 3
Positive n = 0
Positive n = 16 Negative n = 6 Negative n = 4
Lost to follow up n = 2
Positive n = 0
Culture not obtained n = 3 Negative n = 3
Lost to follow up n = 0
Positive n = 1
Positive n = 7 Negative n = 3
Lost to follow up n = 3
Positive n = 3
Negative n = 41 Negative n = 27 Negative n = 20
Lost to follow up n = 4
Positive n = 0
Culture not obtained n = 7 Negative n = 5
Lost to follow up n = 2
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The studied cohort had a female preponderance and a
median age of 19 years, which is representative for this
group of patients according to the National Tonsil
Surgery Register in Sweden (Stahlfors, pers comm). The
number of included patients was lower than estimated,
rising doubts about the representativity of the cohort. To
address this question, a review of all tonsillectomies
performed at Växjö Central Hospital during the time of the
study showed that 80 % of patients meeting inclusion
criteria had been included. This was considered an accept-
able inclusion rate, even though a larger number of in-
cluded patients would have been preferable. Seventy-five
per cent of patients completed all three visits despite the
high geographical mobility of the affected age group and
the lack of clinical advantages associated with the follow-up
visit. The drop-out rate was thus likewise considered
acceptable.
Tonsil core biopsies and PCR-based techniques have
been advanced as more sensitive methods for the detec-
tion of F. necrophorum than the surface swabs and se-
lective culture used in this study [14, 22]. Considering
that core biopsies are not an option in the clinical real-
ity, and because they would not have been possible to
compare with pre- or postoperative results, we used
surface swabs for sampling. Regarding detection by PCR,
it is not clear whether the increase in sensitivity increases
the predictive value of a finding of F. necrophorum in the
clinical setting. We chose selective culture as this is the
method used in our clinical everyday practice.
We found a high prevalence of F. necrophorum in this
cohort, like in previous studies of similar patient groups
[4, 13, 19]. Among patients with acute infection at the
time of sampling, F. necrophorum was found in an even
higher proportion, consistent with earlier studies show-
ing that F. necrophorum is frequently found in periton-
sillar abscess and acute tonsillitis in adolescents and
young adults [4, 13, 16, 21]. Notably, the finding of
F. necrophorum varied at different times in the same
individual, suggesting that oropharyngeal carriage of this
bacterium is transient. Some patients acquired the bac-
terium during the follow-up time while others, initially
colonised, lost it. This finding should be interpreted with
some caution, as PCR-based detection and or a more
standardised sampling method might have shown residual
colonisation with F. necrophorum in lower numbers.
Kissing contacts have previously been suggested as a risk
factor for carriage of F. necrophorum [20] and a partner
could thus be an important source of re-colonisation.
Interestingly, the prevalence of F. necrophorum in the
cohort was equal at all three sampling times. Even at
follow-up, when all patients but one were cured from
their throat symptoms, F. necrophorum was found in
16 % of patients. The lack of correlation between symp-
tomatology and presence of F. necrophorum in postoperative
swabs suggests that the bacterium loses its pathogenic poten-
tial in the absence of tonsillar tissue. Another possible
interpretation is that F. necrophorum does not play a patho-
genic role in this group of patients, but is found merely as an
asymptomatic colonisation. The causality may also differ
between patients in the cohort depending on their indica-
tion for tonsillectomy. Indeed, previous studies have
shown F. necrophorum to be an important pathogen in
peritonsillar abscesses [4, 16]. This has been further sup-
ported by a recent Danish study showing that patients
with growth of F. necrophorum in aspirates from periton-
sillar abscesses also develop specific serum antibodies
against the bacterium [23]. However, while growth of
F. necrophorum in throat swabs is a common finding in
recurrent and chronic tonsillitis, serological evidence is
lacking for a causal role in these conditions [23].
Similarly to the epidemiology of GAS in children, we
hypothesize a transient oropharyngeal colonisation of F.
necrophorum in adolescents and young adults with the po-
tential to cause infection under certain circumstances.
Concurrent infection with Epstein-Barr virus (EBV) facili-
tating tissue penetration of the tonsillar epithelium and
inducing a transient decrease in T-cell mediated immunity
has been suggested such a circumstance [24–26]. In our
study, no patient showed signs of mononucleosis at any
time during the study and the aspect of co-infection is
therefore not possible to evaluate. Self-reported history of
mononucleosis was in our study not significantly associ-
ated with presence of F. necrophorum in throat swabs.
We suggest that presence of tonsillar tissue is a pre-
requisite for infectivity by F. necrophorum. The bacterium
is evidently able to colonise oropharyngeal membranes of
tonsillectomized individuals, but it might lack ability to
cause clinical symptoms in the absence of tonsillar tissue.
Notably, very few patients were colonised with beta-
haemolytic streptococci at all sampling times.
Conclusions
In conclusion, we found a high prevalence of Fusobacterium
necrophorum both pre- and post-tonsillectomy in our se-
lected patient cohort. Importantly though, F. necrophorum
was not found in all patients and not always associated with
symptoms. Looking at individual patients, the presence of
F. necrophorum in the oropharyngeal flora was transient.
Since F. necrophorum is found in a wide clinical spectrum
from asymptomatic carriage via chronic throat symptoms
to acute and sometimes severe infections, a positive throat
culture or molecular test for F. necrophorum is a true
challenge for the clinician. The lack of evidence-based
guidelines on the management of F. necrophorum in tonsil-
lar disease warrants further research, both on its pathogenic
importance and on the benefits of treatment in other
clinical situations than Lemierre’s syndrome.
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